Specializing in innovation and development within the pharmaceutical intermediates sector, the company has achieved significant success in the R&D and industrial production of synthetic processes for API intermediates represented by semaglutide and tirzepatide. It has also made remarkable progress in chiral amino acid process R&D, particularly in the industrialization of penicillamine. Additionall...